Search

Your search keyword '"Fostira, Florentia"' showing total 537 results

Search Constraints

Start Over You searched for: Author "Fostira, Florentia" Remove constraint Author: "Fostira, Florentia"
537 results on '"Fostira, Florentia"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

2. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

3. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

4. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

6. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

7. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

8. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

10. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

11. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

12. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

13. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

14. Shared heritability and functional enrichment across six solid cancers.

15. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

16. Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

17. Close follow-up of early breast cancer patients in Greece. A single-center survey based on a one-to-one interview with questions. A cross-sectional descriptive study

18. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

20. Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

21. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

22. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

23. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

24. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

25. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

26. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

27. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

28. Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer

29. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

30. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

31. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

32. Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

33. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.

34. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

37. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

38. Figure 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

39. Figure 3 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

40. Figure 6 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

41. Table S2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

42. Data from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

43. Figure 4 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

44. Supplementary Methods 1 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

45. Figure 2 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

46. Figure 5 from ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

Catalog

Books, media, physical & digital resources